Trials / Completed
CompletedNCT04881552
Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 302 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The rapid and complete restoration of coronary flow is a key issue in the management of STEMI. Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy associated with antithrombotic drugs. In daily practice, it is not rare that some patients may achieve reopening of the culprit artery without undergoing any mechanical reperfusion therapy, which is called " spontaneous reperfusion ". The latter is associated with improved outcomes in several studies but none of these studies were done in the modern antithrombotic strategy area including new P2Y12 inhibitors. The aim of this study is to report the incidence, characteristics and outcomes of consecutive patients with STEMI admitted for coronary angiography with angiographic clinical evidence of spontaneous reperfusion in the modern medical antithrombotic strategy associated with primary PCI.
Conditions
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-11-01
- Completion
- 2021-05-01
- First posted
- 2021-05-11
- Last updated
- 2021-05-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04881552. Inclusion in this directory is not an endorsement.